The 5-FU exposure when combined with MKK3 silencing resulted into boosting of the chemotherapeutic effects in all of the tested CRC lines (Fig. 3a), including those insensitive to MKK3 depletion-induced autophagy (SW480, SW620) (Fig. 3a). The gene discussed is MAP2K3; the disease is colorectal carcinoma.